DNA icon

Ginkgo Bioworks

348 hedge funds and large institutions have $2.25B invested in Ginkgo Bioworks in 2023 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 141 increasing their positions, 59 reducing their positions, and 17 closing their positions.

Holders
348
Holders Change
+33
Holders Change %
+10.48%
% of All Funds
5.55%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
56
Increased
141
Reduced
59
Closed
17
Calls
$7.89M
Puts
$7.78M
Net Calls
+$119K
Net Calls Change
+$1.73M
Name Market Value Shares Shares
Change
Shares
Change %
BCM
351
Bourgeon Capital Management
Connecticut
-100,000 Closed
Parallax Volatility Advisers
352
Parallax Volatility Advisers
California
-99,855 Closed
VIA
353
Vident Investment Advisory
Georgia
-82,135 Closed
JIC
354
Joel Isaacson & Co
New York
-48,129 Closed
CSS
355
Cubist Systematic Strategies
Connecticut
-41,000 Closed
TSS
356
Two Sigma Securities
New York
-40,063 Closed
EGM
357
Engineers Gate Manager
New York
-39,138 Closed
ECM
358
ExodusPoint Capital Management
New York
-28,101 Closed
DCM
359
Dimension Capital Management
Florida
-15,953 Closed
BC
360
Brookfield Corp
Ontario, Canada
-11,615 Closed
SWA
361
Stratos Wealth Advisors
Ohio
-10,200 Closed
CA
362
Crewe Advisors
Utah
-5,000 Closed
SS
363
Sunbelt Securities
Texas
-1,000 Closed
WAM
364
Worth Asset Management
Texas
-600 Closed
C
365
Covestor
United Kingdom
$0 162 -66 -29%
SM
366
Skaana Management
New York
LP
367
LMR Partners
United Kingdom
CFGS
368
Concourse Financial Group Securities
Alabama
AW
369
Avion Wealth
Texas
$0 787
KPF
370
K2 Principal Fund
Ontario, Canada